CD25 Chimeric Antigen Receptor Patent Granted to Montefiore Medical Center

Tue, 21 Apr 2026 14:20:15 +0000
Intellectual Property

USPTO granted US Patent US12606630B2 to Montefiore Medical Center covering CD25 chimeric antigen receptors and their therapeutic uses. The patent, applied for in August 2020, contains 19 claims covering compositions and methods for immune enhancement and cancer treatment. This grant confers exclusive intellectual property rights to the assignee for the claimed biological compositions and treatment methods.